Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination

Authors

  • Gil Armoni-Weiss
  • Sivan Sheffer-Levi
  • Liran Horev
  • Laurent Klapholz
  • Emily Avitan-Hersh
  • Abraham Zlotogorski Department of Dermatology, Hadassah Medical Center, Hebrew University of Jerusalem, Faculty of Medicine, 9112001 Jerusalem, Israel
  • Yuval Ramot

DOI:

https://doi.org/10.2340/00015555-3907

Keywords:

Hailey-Hailey, SARS-CoV-2, COVID-19, mRNA vaccine, vaccination, genodermatosis

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Follmann D, Fintzi J, Fay MP, Janes HE, Baden L, Sahly HE, et al. Assessing durability of vaccine effect following blinded crossover in COVID-19 vaccine efficacy trials. medRxiv 2020 Dec 14:2020.12.14.20248137 (Preprint).

Tran TN, Wikle N, Albert J, Inam H, Strong E, Brinda K, et al. Optimal SARS-CoV-2 vaccine allocation using real-time seroprevalence estimates in Rhode Island and Massachusetts. medRxiv 2021 Jan 15:2021.01.12.21249694 (Preprint).

Engin B, Kutlubay Z, Celik U, Serdaroglu S , Tuzun Y. Hailey-Hailey disease: a fold (intertriginous) dermatosis. Clin Dermatol 2015; 33: 452–455.

Chlebicka I, Jankowska-Konsur A, Maj J, Plomer-Niezgoda E, Szepietowski JC. Generalized Hailey-Hailey disease triggered by nonsteroidal antiinflammatory drug-induced rash: case report. Acta Dermatovenerol Croat 2012; 20: 201–203.

Wang F, Kream RM , Stefano GB. An evidence based perspective on mRNA-SARS-CoV-2 vaccine development. Med Sci Monit 2020; 26: e924700.

McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol 2021; 85: 46–55.

Downloads

Published

2021-09-22

How to Cite

Armoni-Weiss, G., Sheffer-Levi, S., Horev, L., Klapholz, L., Avitan-Hersh, E., Zlotogorski, A., & Ramot, Y. (2021). Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination. Acta Dermato-Venereologica, 101(9), adv00554. https://doi.org/10.2340/00015555-3907

Issue

Vol. 101 No. 9 (2021): September

Section

Short Communication

Categories

License

Copyright (c) 2021 Gil Armoni-Weiss, Sivan Sheffer-Levi, Liran Horev, Laurent Klapholz, Emily Avitan-Hersh, Abraham Zlotogorski, Yuval Ramot

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.

Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.

Crossref
Scopus
Google Scholar
Europe PMC